Northwest Biotherapeutics (NWBO) Files $100M Mixed Shelf
Tweet
Share
E-mailGet Alerts NWBO Hot Sheet
Join SI Premium – FREE
Northwest Biotherapeutics (NASDAQ: NWBO) filed a registration with the U.S. SEC to sell, from time to time, up to $100 million of Common Stock, Preferred Stock, Debt Securities, Warrants, Stock Purchase Contracts, Units, or any combination thereof.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zeo Energy Corp (ZEO) files $150M mixed shelf
- AN2 Therapeutics names Cameron Trenor as chief medical officer
- Alnylam to present ATTR and hypertension data at ESC 2026
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
